Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Nixon

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Health Economics|June 10, 2005
Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluationsRichard M Nixon, Simon G Thompson
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 3, 2005
How sensitive are cost-effectiveness analyses to choice of parametric distributions?Simon G Thompson, Richard M Nixon
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 11, 2002
A comparison of clinical assessment with ultrasound in the management of secondary postpartum haemorrhageAnneMarie C Neill, Richard M Nixon, Steven Thornton
Health Economics|April 21, 2009
Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap comparedRichard M Nixon, David Wonderling, Richard D Grieve
Journal of Health Economics|March 17, 2006
Addressing the issues that arise in analysing multicentre cost data, with application to a multinational studySimon G Thompson, Richard M Nixon, Richard Grieve
BMC Medical Research Methodology|September 26, 2003
Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpointRichard M Nixon, Stephen W Duffy, Guy R K Fender
BMC Medical Research Methodology|December 24, 2014
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusionHoward H Z Thom, Gorana Capkun, Richard M Nixon, et al.
Pharmaceutical Statistics|October 24, 2008
Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritisRichard M Nixon, Nick Bansback, John W Stevens, et al.
BMC Medical Research Methodology|April 19, 2015
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertensionHoward H Z Thom, Gorana Capkun, Annamaria Cerulli, et al.
Arthritis and Rheumatism|April 3, 2008
Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysisAllan J Wailoo, Nick Bansback, Alan Brennan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Health Economics|June 10, 2005
Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluationsRichard M Nixon, Simon G Thompson
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 3, 2005
How sensitive are cost-effectiveness analyses to choice of parametric distributions?Simon G Thompson, Richard M Nixon
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 11, 2002
A comparison of clinical assessment with ultrasound in the management of secondary postpartum haemorrhageAnneMarie C Neill, Richard M Nixon, Steven Thornton
Health Economics|April 21, 2009
Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap comparedRichard M Nixon, David Wonderling, Richard D Grieve
Journal of Health Economics|March 17, 2006
Addressing the issues that arise in analysing multicentre cost data, with application to a multinational studySimon G Thompson, Richard M Nixon, Richard Grieve
BMC Medical Research Methodology|September 26, 2003
Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpointRichard M Nixon, Stephen W Duffy, Guy R K Fender
BMC Medical Research Methodology|December 24, 2014
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusionHoward H Z Thom, Gorana Capkun, Richard M Nixon, et al.
Pharmaceutical Statistics|October 24, 2008
Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritisRichard M Nixon, Nick Bansback, John W Stevens, et al.
BMC Medical Research Methodology|April 19, 2015
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertensionHoward H Z Thom, Gorana Capkun, Annamaria Cerulli, et al.
Arthritis and Rheumatism|April 3, 2008
Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysisAllan J Wailoo, Nick Bansback, Alan Brennan, et al.
Pageof 2